Melanotan I
Research Compound · 1 vial x 10mg
$31
| Pack size | 1 vial x 10mg |
| Also known as | Afamelanotide; [Nle4, D-Phe7]-α-MSH; NDP-MSH |
| Compound type | Synthetic tridecapeptide; MC1 receptor agonist |
| Sequence | Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
| Molecular formula | C78H111N21O19 |
| Molecular weight | 1646.9 g/mol |
| CAS number | 75921-69-6 |
| Form | Lyophilized powder |
| Purity | 99% Pure |
| Storage | Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol. |
| Intended use | Laboratory research only |
This product is sold exclusively for laboratory research use by qualified professionals and institutions. It is not a drug, food, cosmetic, or dietary supplement, and is not approved for use in humans or animals. Handling must be performed only by trained personnel in a controlled research setting.
Research overview
Melanotan I (afamelanotide) is a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone (α-MSH) that binds mainly the MC1 receptor. As afamelanotide it was approved in the EU in 2015 and the US in 2019 for patients with erythropoietic protoporphyria.
Research areas
- MC1 receptor pharmacology
- Melanogenesis
- Photoprotection research
Sources
Handling and storage
Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol.